Efficacy of Rituximab Biosimilar in Follicular Lymphoma

A phase III study looks at the efficacy and safety of rituximab biosimilar CT-P10 in patients with follicular lymphoma.

Source: CancerNetwork - November 27, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news